Form 8K LB Pharmaceuticals Inc For: 15 September
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
LB Pharmaceuticals Inc (LBRX)
LB Pharmaceuticals Inc stock price live, this page displays NASDAQ LBRX stock exchange data. View the LBRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the LB Pharmaceuticals Inc real time stock price chart below.
What Is the LB Pharmaceuticals Inc Stock Price Today?
The LB Pharmaceuticals Inc stock price today is 42,47.
What Is the Stock Symbol for LB Pharmaceuticals Inc?
The stock symbol for LB Pharmaceuticals Inc is "LBRX."
What Stock Exchange Does LB Pharmaceuticals Inc Trade On?
LB Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is LB Pharmaceuticals Inc a Good Stock to Buy?
Determining whether LB Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LBRX quote. (ISIN: US50180M1080)
What Is the LB Pharmaceuticals Inc Stock Price Today?
The LB Pharmaceuticals Inc stock price today is 42,47.
What Is the Stock Symbol for LB Pharmaceuticals Inc?
The stock symbol for LB Pharmaceuticals Inc is "LBRX."
What Stock Exchange Does LB Pharmaceuticals Inc Trade On?
LB Pharmaceuticals Inc is listed and trades on the NASDAQ stock exchange.
Is LB Pharmaceuticals Inc a Good Stock to Buy?
Determining whether LB Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the LBRX quote. (ISIN: US50180M1080)
NASDAQ
Currency in USD
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.39
42.54
52 wk Range
13.36
50.16
LBRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
41.3942.54
52 wk Range
13.3650.16
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
LBRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
53.38
Upside
+25.68%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
5 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Neutral
Moving Averages
Neutral
Analyst Ratings
8 Buy
0 Hold
0 Sell
Ratings:
8 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 53.38
(+25.68% Upside)
Earnings
Latest Release
Aug 11, 2026
EPS / Forecast
-1,71 / -0,78
Revenue / Forecast
-- / --
Compare LBRX to Peers and Sector
Metrics to compare | LBRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipLBRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −16.0x | −3.9x | −0.4x | |
PEG Ratio | −0.17 | −0.83 | 0.00 | |
Price/Book | 4.1x | −13.5x | 2.6x | |
Price / LTM Sales | - | 2.5x | 3.0x | |
Upside (Analyst Target) | 25.7% | 90.8% | 54.5% | |
Fair Value Upside | Unlock | 6.1% | 7.2% | Unlock |
LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 2 clinical trial for the treatment of bipolar I depression; adjunctive treatment of MDD; and in pre-clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the LB Pharmaceuticals (LBRX) Stock Price Today?
The LB Pharmaceuticals stock price today is 42,47 USD.
What Stock Exchange Does LB Pharmaceuticals Trade On?
LB Pharmaceuticals is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for LB Pharmaceuticals?
The stock symbol for LB Pharmaceuticals is "LBRX."
What Is the LB Pharmaceuticals Market Cap?
As of today, LB Pharmaceuticals market cap is 1,37B USD.
What Is LB Pharmaceuticals's Earnings Per Share (TTM)?
The LB Pharmaceuticals EPS (TTM) is -3,81.
When Is the Next LB Pharmaceuticals Earnings Date?
LB Pharmaceuticals will release its next earnings report on Nov 05, 2026.
From a Technical Analysis Perspective, Is LBRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has LB Pharmaceuticals Stock Split?
LB Pharmaceuticals has split 0 times.
How Many Employees Does LB Pharmaceuticals Have?
LB Pharmaceuticals has 49 employees.
What is the current trading status of LB Pharmaceuticals (LBRX)?
As of Sep 20, 2026, LB Pharmaceuticals (LBRX) is trading at a price of 42,47 USD, with a previous close of 42,47 USD. The stock has fluctuated within a day range of 41,39 USD to 42,54 USD, while its 52-week range spans from 13,36 USD to 50,16 USD.
What Is LB Pharmaceuticals (LBRX) Price Target According to Analysts?
The average 12-month price target for LB Pharmaceuticals is 53,38 USD, with a high estimate of 78 USD and a low estimate of 37 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +25,68% Upside potential.
What Is the LBRX Premarket Price?
LBRX's last pre-market stock price is 43,00 USD. The pre-market share volume is 70,00, and the stock has decreased by 0,86, or 2,04%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.